American Marconi Wireless News - News from Boston, Massachusetts, the USA and the world, around the clock every day

Putting the "Paper When Possible, Plastic When Useful" Principle into Action

BRIDGEWATER, NEW JERSEY / ACCESS Newswire / April 28, 2025 / Tharimmune, Inc., (Nasdaq:THAR) ("Tharimmune" or the "Company") a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology, recently announced positive feedback from the U.S. Food and Drug Administration (FDA) regarding TH104. The agency confirmed that no additional clinical trials appear to be necessary prior to a 505(b)(2) New Drug Application (NDA) submission. TH104 is a buccal film formulation, of nalmefene specifically designed for rapid absorption with a potential for bypassing liver metabolism. This allows TH104 to be suitable for the temporary prophylaxis of respiratory and/or nervous system depression in military personnel and chemical incident responders who may be exposed to high-potency opioids, including weaponized fentanyl and its analogues.

SOLANA BEACH, CA / ACCESS Newswire / April 28, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, announces that today its partner, Clinical Laserthermia Systems AB (publ) (CLS), completed the submission of its 510(k) application to the FDA, expanding the indication of the ClearPoint Prism Neuro Laser Therapy System to include 1.5 T MRI guidance.

Company thanks the outgoing CEO for his many years of oversight that has accelerated growth in Afinida and Trucept companies.

Ambient AI technology that seamlessly integrates into the EHR to improve ED and inpatient documentation and clinical workflows

Clear Start Tax Shares What Not to Do When You’re Behind With the IRS—and the Smartest Ways to Start Resolving Your Debt

AUSTIN, TX / ACCESS Newswire / April 28, 2025 / Living Security, the global leader in human risk defense, today unveils powerful adaptive intelligence capabilities within its Unify platform. By fusing human expertise from its Human Intelligence Team (HInT), advanced AI phishing simulations, and industry-wide threat telemetry, Unify now delivers a minimum of 3X more visibility into human risk compared to outdated security awareness tools. This advancement is validated by third-party research from Cyentia.

LONDON, GB / ACCESS Newswire / April 28, 2025 / The Progressive Supranuclear Palsy (PSP) Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and Anne-Marie Wills (Massachusetts General Hospital), has selected two promising drug candidates-Axon Neuroscience's AADvac1 and Alzprotect's AZP2006-for inclusion in the platform trial as the first two compounds to be evaluated. The trial aims to accelerate the development of effective treatments for PSP, a rare and fatal neurodegenerative disease. Additional compounds to be evaluated in the trial are expected to be announced later this year.

Latest Agreements Continue Network's Rapid Global Growth in Over 100 Countries Across Five Continents

The webcast will review the MVID and SBS-IF patient experience, the impact of crofelemer on disease progression and quality of life in MVID and SBS-IF, and possible expedited regulatory pathways for crofelemer for MVID; Click here to registerThere are currently no approved drug treatments for MVID, an ultrarare pediatric disease characterized by severe diarrhea and malabsorption that requires intensive parenteral support for nutritional and fluid managementThis data was presented at the Annual ELITE PED-GI Congress by Dr. Mohamad Miqdady, a recognized leader in pediatric gastroenterology and the primary investigator for this study

Initial order in Europe highlights Ondas' continued momentum as an emerging defense technology prime contractor, delivering next-generation autonomous systems to address evolving aerial threats and support critical national security operationsThis latest purchase order builds on a series of international contracts and operational milestones, reinforcing the Company's rapid growth and expanding presence in defense and security markets

tZERO's Special Purpose Broker Dealer (one of two in the US) and Tokenization Unit continue to lead compliant Digital Securities end-to-end lifecycle, new capabilities to enhance transparency, facilitate additional utility features and enable third-party broker-dealer interoperability in the future

PHOENIX, ARIZONA / ACCESS Newswire / April 28, 2025 / Crexendo®, Inc. (NASDAQ:CXDO), an award-winning software technology company that is a premier provider of cloud communication platform software and unified communication as a service (UCaaS) offerings, including voice, video, contact center, and managed IT services tailored to businesses of all sizes, today announced that VOIPLY, a rapidly growing nationwide cloud communications provider for business and residential customers, has selected Crexendo's NetSapiens platform as their next generation growth platform.

CHINO HILLS, CA / ACCESS Newswire / April 28, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, proudly announces today its collaboration and licensing agreement with an undisclosed emerging drug development partner. This partnership accentuates SOHM's leadership in gene editing and cell engineering.

HACKENSACK, NJ / ACCESS Newswire / April 28, 2025 / Champions Oncology (NASDAQ:CSBR), a leader in translational oncology research, has been granted a license to use radioactive materials in preclinical studies. This approval allows in-house work utilizing a variety of clinically relevant radionuclides, significantly expanding the organization's capabilities in the development and assessment of targeted radiotherapeutics.

CHENGDU, CHINA / ACCESS Newswire / April 28, 2025 / Wetouch Technology Inc. (Nasdaq:WETH) ("Wetouch" or the "Company") a leading provider of medium to large sized projected capacitive touchscreens, today announced its unaudited financial results for the year ended December 31, 2024. The company reported revenue of $42.3 million and earnings per share (EPS) of $0.48, reflecting strong performance across its diverse client base.

ROCKY MOUNT, NC / ACCESS Newswire / April 28, 2025 / Ted E. Whitehurst, President and CEO of PB Financial Corporation (OTCQX:PBNC), the holding company for Providence Bank, announced today that the Board of Directors approved a quarterly cash dividend of $0.58 per share on common stock outstanding to shareholders of record at the close of business on May 8, 2025. The dividend is payable on May 23, 2025. This is an increase of approximately 9.43% from the dividend paid during the 2nd quarter of 2024. This represents a $2.32 per share dividend on an annualized basis and a dividend yield of approximately 4.99% (based on closing price on April 25, 2025 of $46.50 per share).

STURGIS, MI / ACCESS Newswire / April 28, 2025 / Sturgis Bancorp, Inc. (OTCQX:STBI) today reported for the first quarter of 2025:

MIAMI, FLORIDA / ACCESS Newswire / April 28, 2025 / SMX Plc. (NASDAQ:SMX) just turbocharged its global expansion with not one but two transformative partnerships in the ASEAN region. In the span of a week, SMX announced inking high-impact agreements with Aegis Packaging and Skypac Packaging - Singapore-based leaders in coating technologies and flexible plastics, respectively. These deals are beyond milestones scored - they mark a powerful swing in commercial momentum that positions SMX as a dominant, even irreplaceable, force in the unyielding drive toward a transparent and accountable circular economy.

TEL AVIV, IL / ACCESS Newswire / April 28, 2025 / Shelfie-Tech Ltd. (the "Company" or "Shelfie"), is pleased to announce that it has received a letter from the Canadian Securities Exchange (the "CSE") confirming conditional approval to list its common shares for trading on the CSE (the "Listing"). The Conditional Approval follows the receipt by Shelfie of a receipt for its (Final) Long Form Prospectus dated April 22, 2025 relating to the securities of Shelfie (the "Prospectus"). A copy of the Prospectus can be found under the Company's profile at www.sedarplus.ca.

TAMPA, FL / ACCESS Newswire / April 28, 2025 / Just as spring ushers in feelings of renewal, so does Lil' Red, the new bestselling memoir by author Jill Safari. In its pages, readers are invited into a deeply personal story of pain, survival, and ultimately, forgiveness. This book is an account of lived experience - offering insight into what often goes unseen behind closed doors and the resilience it takes to move forward. In a brave search to heal from past pain and trauma, Jill's memoir details how to face our pain, move through it, and allow room for forgiveness and renewal of spirit.

TAIPEI, TW / ACCESS Newswire / April 28, 2025 / Nocera, Inc., a Nevada corporation (NASDAQ:NCRA) ("Nocera" or the "Company"), a fully integrated sustainable seafood company focusing on manufacturing and operating land-based Recirculatory Aquaculture Systems ("RASs"), today announced that it received a letter from the Nasdaq Stock Market LLC ("Nasdaq") dated April 24, 2025, notifying the Company that, because it has not yet filed its Annual Report on Form 10-K for the year ended December 31, 2024 (the "Form 10-K"), it is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission (the "SEC").

LOS ANGELES, CA / ACCESS Newswire / April 28, 2025 / In the heart of Beverly Hills, Dr. Hooman Melamed is redefining spine surgery with cutting-edge motion-sparing technologies - offering renewed hope to patients once told spinal fusion was their only option. As a world-renowned Orthopedic Spine Surgeon, Dr. Melamed's pioneering techniques are reshaping outcomes for those suffering from debilitating spine conditions like Spinal Canal Stenosis, Scoliosis, Kyphosis, Sciatica, Radiculopathy, Back pain, Neck pain, Myelopathy, Disc Extrusion, Degenerative Disc Disease, and Degenerative Joint Disease.

COLORADO SPRINGS, COLORADO / ACCESS Newswire / April 28, 2025 / Fortitude Gold (OTCQB:FTCO) (the "Company") today announced the timing of its 2025 first quarter earnings conference call scheduled for Wednesday, April 30, 2025. Fortitude Gold is a gold producer, developer, and explorer with operations in Nevada, U.S.A. offering investors exposure to both gold production and dividend yield.

LOS ANGELES, CA / ACCESS Newswire / April 28, 2025 / In the realm of spinal disorders, few conditions are as elusive - and misunderstood - as Thoracic Myelopathy. This severely underdiagnosed condition leaves countless patients navigating a maze of doctors, tests, and misdiagnoses, often being told that nothing is wrong despite persistent, unexplained symptoms. Dr. Hooman Melamed, an esteemed Orthopedic Spine Surgeon in Beverly Hills Los Angeles County, is redefining the approach to this complex disorder with a groundbreaking, motion-sparing surgical technique that combines precision, innovation, and faster recovery - all without relying on narcotics.

Almas Jiwani Joined as VIP Guest Invited by His Royal Highness Prince Abdulaziz bin Faisal Al Saud

Not for distribution to U.S. Newswire Services or for dissemination in the United States of America. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

TAMPA, FL / ACCESS Newswire / April 28, 2025 / Acclaimed children's author Judi Marxer returns with two delightfully engaging children's books that are already winning the hearts of parents, teachers, and young readers alike. With the release of Jonathan's Book and Lina and Pella: The Rainforest Adventure, Marxer continues her mission to create wholesome, imaginative stories that inspire empathy, curiosity, and a lifelong love of storytelling.

KELOWNA, BC / ACCESS Newswire / April 28, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced the closing of its previously announced registered direct offering with a single institutional investor for the purchase and sale of 2,000,000 shares of common stock (or pre-funded warrants in lieu thereof) at a purchase price of $1.00 per share (or per pre-funded warrant in lieu thereof) Other than the pre-funded warrants, no other warrants were issued to the institutional investor in the registered direct offering.

LITTLETON, CO / ACCESS Newswire / April 28, 2025 / Ur-Energy Inc. (NYSE American:URG)(TSX:URE) (the "Company" or "Ur-Energy") is pleased to announce the Wyoming Department of Environmental Quality, Land Quality Division ("LQD") has granted approval of the LC East HJ and KM amendments to the Lost Creek Permit to Mine. This permitting action grants final State approval for Ur-Energy to construct and operate up to six additional mine units within the HJ and KM geologic horizons at our LC East Project and in the HJ horizon at Lost Creek.

DÜSSELDORF, GERMANY, ATLANTA, GA, AND NEW YORK, NY / ACCESS Newswire / April 28, 2025 / As previously disclosed, and pursuant to the terms and conditions set forth in the Share Purchase Agreement, dated as of July 25 and 26, 2023, by and among Heramba GmbH ("Heramba"), Heramba Holdings, Inc. ("Heramba Holdings"), Knorr-Bremse Systeme für Schienenfahrzeuge GmbH ("KB GmbH") and Knorr-Brake Holding Corporation ("KB US"), as amended pursuant to the Amendment Agreement to Share Purchase Agreement, dated as of January 31, 2024, on February 6, 2024, (i) KB GmbH, as sole shareholder of Kiepe Electric GmbH, sold and transferred 85% of the equity interests in Kiepe GmbH, as well as certain receivables and shareholder loans, to Heramba, and (ii) KB US, as the sole member of Kiepe Electric LLC ("Kiepe US" and together with Kiepe GmbH, "Kiepe"), sold and transferred all ownership interests in Kiepe US, as well as certain receivables, to Heramba Holdings.

VANCOUVER, BC / ACCESS Newswire / April 28, 2025 / CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) ("CoTec" or the "Company") is pleased to announce that it has filed its audited annual financial statements and the accompanying management discussion and analysis for the financial year ended December 31, 2024. The Company reported net income of $0.5 million and net loss of $0.2 million for the quarter and the year, respectively.